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X-ray repair cross-complementing group 1 (XRCC1) is a major DNA
repair gene involved in BER mutation. Polymorphisms in DNA
repair genes associated with repair efﬁciency against DNA damage
may predispose an individual's cancer susceptibility. Data from
cervical cancer patients was collected from South Indian Women.
Genotyping of XRCC1 polymorphisms (194C/T, 280G/A and 399G/
A) was done by polymerase-chain-reaction with the confronting-
two-pair primer (PCR-CTPP) method.
& 2016 The Authors. Published by Elsevier Inc. This is an open
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G. Konathala et al. / Data in Brief 10 (2017) 11–1312xperimental
featuresGenotyping of three SNPs by polymerase-chain-reaction with the
confronting-two-pair primer (PCR-CTPP) method.ata source
locationMahatma Gandhi cancer Hospital, King George Hospital and Lions Cancer
Hospital, Visakhapatnam, Andhra Pradesh, India.ata accessibility Data are presented in this articleD
Value of the data
 Only few works on cervical cancer have been carried out from India. Especially, no data is available
on DNA repair genes polymorphisms of cervical cancer from north coastal Andhra Pradesh. This
data may ﬁll the gap from this region.
 To acquire the knowledge of XRCC1 allelic proﬁles and genotype distribution in the normal
population and patients to observe their association with risk of cervical cancer.
 The Multifactor Dimensionality Reduction (MDR) method was used to assess higher order gene-
gene interactions that may confer high or low-risk for cervical cancer development using genotype
data on three SNPs.
 This data is useful to determine the genetic diversity from this region.1. Data
Tables 1 and 2 describe the Association, Relative Risk and Odds Ratio of XRCC1 (194C4T),
(280G4A), (399G4A) genotypes in disease and control groups. Table 3 summarizes the comparative
table of polymorphisms of DNA repair gene XRCC1. Graphs 1 and 2 represent the best double and
three-locus bar diagrams. Fig. 1 illustrates the MDR interaction information analysis of the three
polymorphisms, represented in the form of a dendrogram. Pairwise linkage disequilibrium (LD) for
three SNPs were calculated. The analysis has generated 8 marker combinations from three SNPs in
both cases and controls (Table 4; Graph 3).2. Experimental design, materials and methods
2.1. Subjects
This research was designed to be a case-control study. The study was ethically approved for col-
lecting blood samples from the human subjects by the local [Andhra University] ethics committee.
125 patients who were diagnosed with cervical cancer at King George Government Hospital, Lions
Cancer Hospital and Mahatma Gandhi Cancer Hospital and Research Institute, Visakhapatnam,
Andhra Pradesh, India were recruited. Around 150 control samples were collected and analyzed for
the molecular parameters.
2.2. DNA extraction
Genomic DNA was obtained from 1 ml of EDTA anticoagulated whole blood by the salting-out
method with slight modiﬁcations [1]. Both cases and controls were genotyped in a randomized,
blinded fashion.
2.3. Determination of XRCC1 genotype
Genotyping of XRCC1 polymorphisms (194C/T, 280G/A and 399G/A) was made by polymerase-
chain-reaction with the confronting-two-pair primer (PCR-CTPP) method [2]. PCRs were carried out
in a total volume of 15 μl.
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2
394C/T NF: 50 CCCTTTGGCTTGAGTTTTGT 30; MF: 50 GGGCTCTCTTCTTCAGCT 30NR: 50 GGGATGTCTTGTTGATCCG 30; MR:50 TGCTGGGTCGCTGGCTGTG 3080G/A NF: 50 CTCTTCCCAAGAGACCTAAAT 30; MF: 50 TCCAGTGCCAGCTCCAACTCA 30NR: 50 ACTGGGGCTGTGGCTGGGGTAC 30; MR: 50 TAGGGCCTTATCTCGCAGCTC 3099G/A NF: 50 ATCCTTCAGGGTGTGGTAGTG 30; MF: 50 GTCGGCGGCTGCCCTCCCG 30NR: 50 TGGCGTGTGAGGCCTTACCTCT 30; MR: 50 TCCCACCCCTGAGTTTTTGCAC 30The primers were designed by using primer 3plus software (http://primer3plus.com/cgi-bin/dev/
primer3plus.cgi). PCR ampliﬁcation was performed in a thermal cycler gradient PCR system (Lark,
India). The PCR ampliﬁcation was performed for 30 cycles (denaturation at 95 °C for 20 s, annealing
for 30 s at 56 °C, extension at 72 °C for 20 s and ﬁnal extension for 5 min at 72 °C. PCR products of
608 bp (194 C/T), 747 bp (280 G/C) and 837 bp (399 G/C) were analyzed by 1.5% agarose gel stained
with ethidium bromide.Acknowledgments
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